August 2017 FDA Recall Paroxetine by Zydus Pharmaceuticals Usa Inc
D-1137-2017 - Presence of Foreign tablets/capsules
This Class II drug recall was voluntarily initiated by Zydus Pharmaceuticals Usa Inc on August 18, 2017 for the product Paroxetine. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.
Recall Number: D-1137-2017
Presence of Foreign tablets/capsules: risperidone Tablets were found in bottle of paroxetine Tablets
08-18-2017
09-20-2017
44800 bottles
Recall Profile & Regulatory Data
Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Enforcement Status About Enforcement Status
Current regulatory stage of the recall event.
Current regulatory stage of the recall event.
Terminated
Recalling Firm About Recalling Firm
The firm responsible for the recall.
The firm responsible for the recall.
Zydus Pharmaceuticals USA Inc
Voluntary / Mandated About Voluntary / Mandated
Indicates if the firm acted on its own or under FDA order.
Indicates if the firm acted on its own or under FDA order.
Voluntary: Firm initiated
Drugs
Initial Notification About Initial Notification
Method by which the firm first notified the public.
Method by which the firm first notified the public.
Letter
Distribution Pattern About Distribution Pattern
General area of initial distribution.
General area of initial distribution.
Nationwide within United States
01-06-2020
Product Description About Product Description
Full technical description of the product.
Full technical description of the product.
Paroxetine tablets USP, 30mg, 30-count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534, NDC 68382-099-06, UPC 3 6838209906 8
Batch or Lot Expiration Information
Lot# : Z701133, Exp 03/19
